The Daily Princetonian
Princeton sues drug companies, pharmacy intermediaries over ‘artificially inflating’ insulin prices
In June, Princeton sued major insulin manufacturers and pharmacy benefit managers, alleging they conspired to artificially ...
More children under 12 in US are being prescribed weight-loss drugs, study finds
Sept 4 (Reuters) - Prescriptions for GLP-1 weight-loss drugs among children under 12 in the U.S. have risen more than 300-fold since 2019 as doctors seek new, effective treatments for younger patients ...
Healthcare Digital
This Week’s Top 5: Novo Nordisk, Eli Lilly, Bupa, UKHSA
This week's top stories include Novo Nordisk's R&D changes, Eli Lilly's Zepbound study, Sweden's PFAS ban, and Bupa APAC's ...
Daily Mail
The link between weight-loss jabs and thyroid cancer: As patients claim their illness was caused by the drugs, our experts reveal fears over high-dosage injections... and …
It is an unsettling question that has emerged alongside the extraordinary rise of the new generation of weight-loss drugs.
Loss of Costco deal helps push Focus Factor maker into Chapter 11
The consumer health company lost Costco as a major retail partner before filing Chapter 11, adding pressure to a business sold at major retailers.
Donga Science
Semaglutide Extends Lifespan in Elderly Female Mice at UC Berkeley
Semaglutide has been shown in animal experiments to improve health and extend lifespan. Provided by Bank. A research team ...
briefs
First trial in younger kids finds 40% on Wegovy no longer obese after a year
First trial in 6-11-year-olds finds 40% on Wegovy fell below obesity cutoff after a year; Novo Nordisk shares steady amid ...